Press release
Gastroesophageal Reflux Disease (GERD) Drugs and Devices Key Trends and Opportunities to 2027Market Research Report: Size, Share, Opportunities, Challenges, Statistics, Restraints, Drivers with Key Players like AstraZeneca, Plc., Addex Therapeutics
LOS ANGELES, United States: QY Research offers an overarching research and analysis-based study on, “Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Key Trends and Opportunities to 2027“. This report offers an insightful take on the drivers and restraints present in the market. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Key Trends and Opportunities to 2027 data reports also provide a 5 year pre-historic and forecast for the sector and include data on socio-economic data of global. Key stakeholders can consider statistics, tables & figures mentioned in this report for strategic planning which lead to success of the organization. It sheds light on strategic production, revenue, and consumption trends for players to improve sales and growth in the global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Key Trends and Opportunities to 2027 Market. Here, it focuses on the recent developments, sales, market value, production, gross margin, and other significant factors of the business of the major players operating in the global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Key Trends and Opportunities to 2027 Market. Players can use the accurate market facts and figures and statistical studies provided in the report to understand the current and future growth of the global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Key Trends and Opportunities to 2027 market.
This report includes assessment of various drivers, government policies, technological innovations, upcoming technologies, opportunities, market risks, restrains, market barriers, challenges, trends, competitive landscape, and segments which gives an exact picture of the growth of the global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Key Trends and Opportunities to 2027 market.
Top Companies/Manufacturers:
AstraZeneca, Plc., Addex Therapeutics, Takeda Pharmaceutical Company Limited, Rottapharm (Meda AB), Pfizer, Inc., Eisai Co. Ltd., The Procter & Gamble Company, Mederi Therapeutics, Aros Pharma, Rottapharm (Meda AB), Pfizer, Inc., EndoGastric Solutions, Medigus Ltd.
Market Segment by Product Type:
, Medication, Minimally Invasive Surgery, Invasive Surgery Gastroesophageal Reflux Disease (GERD) Drugs and Devices Breakdown Data
Market Segment by Application:
Market Analysis and Insights:
Get PDF Sample Copy of the Report Gastroesophageal Reflux Disease (GERD) Drugs and Devices Key Trends and Opportunities to 2027 market
https://www.qyresearch.com/sample-form/form/2658521/global-gastroesophageal-reflux-disease-gerd-drugs-and-devices-key-trends-and-opportunities-to-2027
Do You Have Any Question Or Specific Requirement? Ask to Our Industry Expert:
https://www.qyresearch.com/customize-request/form/2658521/global-gastroesophageal-reflux-disease-gerd-drugs-and-devices-key-trends-and-opportunities-to-2027
Competitive Landscape
Competitor analysis is one of the best sections of the report that compares the progress of leading players based on crucial parameters, including market share, new developments, global reach, local competition, price, and production. From the nature of competition to future changes in the vendor landscape, the report provides in-depth analysis of the competition in the global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Key Trends and Opportunities to 2027 market.
Key questions answered in the report:
What is the growth potential of the Gastroesophageal Reflux Disease (GERD) Drugs and Devices Key Trends and Opportunities to 2027 market?
Which product segment will grab a lion’s share?
Which regional market will emerge as a frontrunner in the coming years?
Which application segment will grow at a robust rate?
What are the growth opportunities that may emerge in the Interactive Patient Engagement Systems industry in the years to come?
What are the key challenges that the global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Key Trends and Opportunities to 2027 market may face in the future?
Which are the leading companies in the global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Key Trends and Opportunities to 2027 market?
Which are the key trends positively impacting the market growth?
Which are the growth strategies considered by the players to sustain hold in the global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Key Trends and Opportunities to 2027 market
Table of Contents
1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type
1.2.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type: 2016 VS 2021 VS 2027
1.2.2 Medication
1.2.3 Minimally Invasive Surgery
1.2.4 Invasive Surgery 1.3 Market by Application
1.3.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Heartburn
1.3.3 Acid reflux disorders 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trend 2.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Perspective (2016-2027) 2.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Growth Trends by Regions
2.2.1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Historic Market Size by Regions (2016-2021)
2.2.3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Forecasted Market Size by Regions (2022-2027) 2.3 Industry Trends and Growth Strategy
2.3.1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Industry Trends
2.3.2 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Drivers
2.3.3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Challenges
2.3.4 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players by Market Size
3.1.1 Players Covered: Ranking by Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue
3.1.2 Global Top Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players by Revenue (2016-2021)
3.1.3 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Players (2016-2021)
3.1.4 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Concentration Ratio
3.2.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 5 and Top 10 Players by Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in 2020 3.3 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Key Players Head office and Area Served 3.4 Key Players Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Solution and Service 3.5 Date of Enter into Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Breakdown Data by Type (2016-2027) 4.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Historic Market Size by Type (2016-2021) 4.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Forecasted Market Size by Type (2022-2027) 5 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Breakdown Data by Application (2016-2027) 5.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Historic Market Size by Application (2016-2021) 5.2 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027) 6.2 Key Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players Market Share in North America (2020-2021) 6.3 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country
6.3.1 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2016-2021)
6.3.2 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country (2022-2027) 6.4 U.S. Market Size Analysis
6.4.1 U.S. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
6.4.2 U.S. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
6.4.3 U.S. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027) 6.5 Canada Market Size Analysis
6.5.1 Canada Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
6.5.2 Canada Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
6.5.3 Canada Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027) 7 Europe 7.1 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027) 7.2 Key Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players Market Share in Europe (2020-2021) 7.3 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country
7.3.1 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2016-2021)
7.3.2 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country (2022-2027) 7.4 Germany Market Size Analysis
7.4.1 Germany Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
7.4.2 Germany Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
7.4.3 Germany Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027) 7.5 France Market Size Analysis
7.5.1 France Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
7.5.2 France Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
7.5.3 France Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027) 7.6 U.K. Market Size Analysis
7.6.1 U.K. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
7.6.2 U.K. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
7.6.3 U.K. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027) 7.7 Italy Market Size Analysis
7.7.1 Italy Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
7.7.2 Italy Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
7.7.3 Italy Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027) 7.8 Russia Market Size Analysis
7.8.1 Russia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
7.8.2 Russia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
7.8.3 Russia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027) 8 Asia-Pacific 8.1 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027) 8.2 Key Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players Market Share in Asia-Pacific (2020-2021) 8.3 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region
8.3.1 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region (2016-2021)
8.3.2 Asia-Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Region (2022-2027) 8.4 China Market Size Analysis
8.4.1 China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
8.4.2 China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
8.4.3 China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027) 8.5 Japan Market Size Analysis
8.5.1 Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
8.5.2 Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
8.5.3 Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027) 8.6 South Korea Market Size Analysis
8.6.1 South Korea Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
8.6.2 South Korea Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
8.6.3 South Korea Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027) 8.7 India Market Size Analysis
8.7.1 India Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
8.7.2 India Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
8.7.3 India Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027) 8.8 Australia Market Size Analysis
8.8.1 Australia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
8.8.2 Australia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
8.8.3 Australia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027) 8.9 Taiwan Market Size Analysis
8.9.1 Taiwan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
8.9.2 Taiwan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
8.9.3 Taiwan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027) 8.10 Indonesia Market Size Analysis
8.10.1 Indonesia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
8.10.2 Indonesia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
8.10.3 Indonesia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027) 8.11 Thailand Market Size Analysis
8.11.1 Thailand Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
8.11.2 Thailand Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
8.11.3 Thailand Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027) 8.12 Malaysia Market Size Analysis
8.12.1 Malaysia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
8.12.2 Malaysia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
8.12.3 Malaysia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027) 8.13 Philippines Market Size Analysis
8.13.1 Philippines Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
8.13.2 Philippines Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
8.13.3 Philippines Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027) 8.14 Vietnam Market Size Analysis
8.14.1 Vietnam Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
8.14.2 Vietnam Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
8.14.3 Vietnam Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027) 9 Latin America 9.1 Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027) 9.2 Key Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players Market Share in Latin America (2020-2021) 9.3 Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country
9.3.1 Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2016-2021)
9.3.2 Latin America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country (2022-2027) 9.4 Mexico Market Size Analysis
9.4.1 Mexico Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
9.4.2 Mexico Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
9.4.3 Mexico Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027) 9.5 Brazil Market Size Analysis
9.5.1 Brazil Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
9.5.2 Brazil Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
9.5.3 Brazil Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027) 9.6 Argentina Market Size Analysis
9.6.1 Argentina Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
9.6.2 Argentina Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
9.6.3 Argentina Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027) 10 Middle East & Africa 10.1 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027) 10.2 Key Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players Market Share in Middle East & Africa (2020-2021) 10.3 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country
10.3.1 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2016-2021)
10.3.2 Middle East & Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country (2022-2027) 10.4 Turkey Market Size Analysis
10.4.1 Turkey Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
10.4.2 Turkey Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
10.4.3 Turkey Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027) 10.5 Saudi Arabia Market Size Analysis
10.5.1 Saudi Arabia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
10.5.2 Saudi Arabia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
10.5.3 Saudi Arabia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027) 10.6 UAE Market Size Analysis
10.6.1 UAE Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (2016-2027)
10.6.2 UAE Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (2016-2027)
10.6.3 UAE Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2016-2027) 11 Key Players Profiles 11.1 AstraZeneca, Plc.
11.1.1 AstraZeneca, Plc. Company Details
11.1.2 AstraZeneca, Plc. Business Overview and Its Total Revenue
11.1.3 AstraZeneca, Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.1.4 AstraZeneca, Plc. Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2016-2021)
11.1.5 AstraZeneca, Plc. Recent Development 11.2 Addex Therapeutics
11.2.1 Addex Therapeutics Company Details
11.2.2 Addex Therapeutics Business Overview and Its Total Revenue
11.2.3 Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.2.4 Addex Therapeutics Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2016-2021)
11.2.5 Addex Therapeutics Recent Development 11.3 Takeda Pharmaceutical Company Limited
11.3.1 Takeda Pharmaceutical Company Limited Company Details
11.3.2 Takeda Pharmaceutical Company Limited Business Overview and Its Total Revenue
11.3.3 Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.3.4 Takeda Pharmaceutical Company Limited Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2016-2021)
11.3.5 Takeda Pharmaceutical Company Limited Recent Development 11.4 Rottapharm (Meda AB)
11.4.1 Rottapharm (Meda AB) Company Details
11.4.2 Rottapharm (Meda AB) Business Overview and Its Total Revenue
11.4.3 Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.4.4 Rottapharm (Meda AB) Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2016-2021)
11.4.5 Rottapharm (Meda AB) Recent Development 11.5 Pfizer, Inc.
11.5.1 Pfizer, Inc. Company Details
11.5.2 Pfizer, Inc. Business Overview and Its Total Revenue
11.5.3 Pfizer, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.5.4 Pfizer, Inc. Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2016-2021)
11.5.5 Pfizer, Inc. Recent Development 11.6 Eisai Co. Ltd.
11.6.1 Eisai Co. Ltd. Company Details
11.6.2 Eisai Co. Ltd. Business Overview and Its Total Revenue
11.6.3 Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.6.4 Eisai Co. Ltd. Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2016-2021)
11.6.5 Eisai Co. Ltd. Recent Development 11.7 The Procter & Gamble Company
11.7.1 The Procter & Gamble Company Company Details
11.7.2 The Procter & Gamble Company Business Overview and Its Total Revenue
11.7.3 The Procter & Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.7.4 The Procter & Gamble Company Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2016-2021)
11.7.5 The Procter & Gamble Company Recent Development 11.8 Mederi Therapeutics
11.8.1 Mederi Therapeutics Company Details
11.8.2 Mederi Therapeutics Business Overview and Its Total Revenue
11.8.3 Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.8.4 Mederi Therapeutics Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2016-2021)
11.8.5 Mederi Therapeutics Recent Development 11.9 Aros Pharma
11.9.1 Aros Pharma Company Details
11.9.2 Aros Pharma Business Overview and Its Total Revenue
11.9.3 Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.9.4 Aros Pharma Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2016-2021)
11.9.5 Aros Pharma Recent Development 11.10 Torax Medical, Inc.
11.10.1 Torax Medical, Inc. Company Details
11.10.2 Torax Medical, Inc. Business Overview and Its Total Revenue
11.10.3 Torax Medical, Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.10.4 Torax Medical, Inc. Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2016-2021)
11.10.5 Torax Medical, Inc. Recent Development 11.11 BD
11.11.1 BD Company Details
11.11.2 BD Business Overview and Its Total Revenue
11.11.3 BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.11.4 BD Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2016-2021)
11.11.5 BD Recent Development 11.12 EndoGastric Solutions
11.12.1 EndoGastric Solutions Company Details
11.12.2 EndoGastric Solutions Business Overview and Its Total Revenue
11.12.3 EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.12.4 EndoGastric Solutions Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2016-2021)
11.12.5 EndoGastric Solutions Recent Development 11.13 Medigus Ltd.
11.13.1 Medigus Ltd. Company Details
11.13.2 Medigus Ltd. Business Overview and Its Total Revenue
11.13.3 Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Introduction
11.13.4 Medigus Ltd. Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices Business (2016-2021)
11.13.5 Medigus Ltd. Recent Development 12 Analyst's Viewpoints/Conclusion 13 Appendix 13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source 13.2 Disclaimer
About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.
QY Research, INC.
17890 Castleton,
Suite 218,
Los Angeles, CA - 91748
Email:
enquiry@qyresearch.com
Web:
https://www.qyresearch.com
-
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Gastroesophageal Reflux Disease (GERD) Drugs and Devices Key Trends and Opportunities to 2027Market Research Report: Size, Share, Opportunities, Challenges, Statistics, Restraints, Drivers with Key Players like AstraZeneca, Plc., Addex Therapeutics here
News-ID: 2319212 • Views: …
More Releases from QYResearch
QYResearch - How To Become A Well -Known Market report Publisher In The World
QYResearch was founded in 2007 and is headquartered in California and Beijing, China.
QY Research cherishes the important value of consulting for enterprises, deeply cultivates the field of segments in the field of research in the industry for more than 13 years, and continues to accumulate, innovate and improve research methods to survive with professionalism, develop with quality, and win more than 50,000 customers in more than 90 countries and regions…
Polydicyclopentadiene (PDCPD) Market to Eyewitness Massive Growth at a CAGR of 7 …
Los Angeles, (United States) - The global Polydicyclopentadiene (PDCPD) revenue was US$ 152.8 million in 2022 and is forecast to a readjusted size of US$ 245.1 million by 2029 with a CAGR of 7.0% during the forecast period (2023-2029). It encompasses a wide range of products, such as industrial chemicals, polymers, plastics, specialty chemicals, paints and coatings, adhesives, metals, ceramics, and composites. The report focuses on the major players that…
Polyvinyl Butyral (PVB) Resins Market 2023 - Quick Action, Powerful Impact: East …
Los Angeles, (United States) - The Polyvinyl Butyral (PVB) Resins industry is a vast and diverse sector that plays a critical role in various other industries, including manufacturing, construction, pharmaceuticals, automotive, and consumer goods. It encompasses a wide range of products, such as industrial chemicals, polymers, plastics, specialty chemicals, paints and coatings, adhesives, metals, ceramics, and composites. The report focuses on the major players that are in operation within the…
VOC Recovery and Abatement Market Research Report: Latest Growth Rate at a CAGR …
Los Angeles, (United States) - The global VOC Recovery and Abatement revenue was US$ 10690 million in 2022 and is forecast to a readjusted size of US$ 51660 million by 2029 with a CAGR of 24.5% during the review period (2023-2029). It encompasses a wide range of products, such as industrial chemicals, polymers, plastics, specialty chemicals, paints and coatings, adhesives, metals, ceramics, and composites. The report focuses on the major…
More Releases for Gastroesophageal
Gastroesophageal Reflux Disease Therapeutics Market
As per the research conducted by GME, the Global Gastroesophageal Reflux Disease Therapeutics Market will grow with a CAGR value of 4.1%. During the forecasted timeframe, the gastroesophageal reflux disease market is likely to be sustained by a rise in the number of patients being treated for gastroesophageal reflux disease and long-term anti-reflux conservation therapy.
Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC…
Gastroesophageal Reflux Disease (GERD) Treatment Devices Market – Latest Devel …
Gastroesophageal Reflux Disease (GERD) Treatment Devices Market report 2018-2026 focuses on the major drivers and restraints for the key players. These research report also provides granular analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. The Gastroesophageal Reflux Disease (GERD) Treatment Devices market research report is a professional and in-depth study on the current state of Gastroesophageal Reflux Disease (GERD) Treatment Devices Industry.
The Gastroesophageal Reflux…
Gastroesophageal Reflux Disease Treatment Devices Market – Global Industry Ins …
Gastroesophageal refers to the stomach and esophagus. Reflux means to return or flow back. Gastroesophageal reflux disease or GERD is a set of conditions, where the lower esophageal sphincter (LES) is affected when the contents of the stomach flows back to the esophagus. In usual digestion process, the lower esophageal sphincter unfastens to let food to pass into stomach and shuts to prevent acidic stomach juices and food from going…
Gastroesophageal Reflux Disease (GERD) Treatment Devices Market - Trends, Outloo …
Gastroesophageal refers to the stomach and esophagus. Reflux means to return or flow back. Gastroesophageal reflux disease or GERD is a set of conditions, where the lower esophageal sphincter (LES) is affected when the contents of the stomach flows back to the esophagus. In usual digestion process, the lower esophageal sphincter unfastens to let food to pass into stomach and shuts to prevent acidic stomach juices and food from going…
Growing Demand in Gastroesophageal Reflux Disease Therapeutics Market Clinical R …
Gastroesophageal Reflux Disease Therapeutics Market report is loaded with point by point analysis from an exhaustive research, particularly on questions that verge on market size, improvement condition, modern advancements, operation circumstance, pathways and pattern of Gastroesophageal Reflux Disease Therapeutics. All these are offshoots of understanding the present circumstance that the business is in, particularly in 2018. The will outline the course for a more complete organization and discernment of the…
Global Gastroesophageal Reflux Disease Therapeutics Market Research Report 2017
Market Research Hub (MRH) has recently publicized a new study to its vast repository, which is titled as “Global Gastroesophageal Reflux Disease Therapeutics Market Research Report 2017”. In this report, the global Gastroesophageal Reflux Disease Therapeutics market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.
Request For Sample Report:…
